These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 3574772)

  • 41. Quantitative receptor autoradiography demonstrates a differential distribution of neuropeptide-Y Y1 and Y2 receptor subtypes in human and rat brain.
    Widdowson PS
    Brain Res; 1993 Dec; 631(1):27-38. PubMed ID: 8298993
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Differential changes in 125I-LSD-labeled 5-HT-2 serotonin receptors in discrete regions of brain in the rat model of persistent dyskinesias induced by iminodipropionitrile (IDPN): evidence from autoradiographic studies.
    Cadet JL; Kuyatt B; Fahn S; De Souza EB
    Brain Res; 1987 Dec; 437(2):383-6. PubMed ID: 3435844
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Microchemical synthesis of the serotonin receptor ligand, 125I-LSD.
    Hartig PR; Krohn AM; Hirschman SA
    Anal Biochem; 1985 Feb; 144(2):441-6. PubMed ID: 3993909
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Regionally-selective down-regulation of NPY receptor subtypes in the obese Zucker rat. Relationship to the Y5 'feeding' receptor.
    Widdowson PS
    Brain Res; 1997 May; 758(1-2):17-25. PubMed ID: 9203528
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Common receptors for hallucinogens in rat brain: a comparative autoradiographic study using [125I]LSD and [125I]DOI, a new psychotomimetic radioligand.
    McKenna DJ; Nazarali AJ; Hoffman AJ; Nichols DE; Mathis CA; Saavedra JM
    Brain Res; 1989 Jan; 476(1):45-56. PubMed ID: 2536576
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Multiple serotonin receptors: differential binding of [3H]5-hydroxytryptamine, [3H]lysergic acid diethylamide and [3H]spiroperidol.
    Peroutka SJ; Snyder SH
    Mol Pharmacol; 1979 Nov; 16(3):687-99. PubMed ID: 530254
    [No Abstract]   [Full Text] [Related]  

  • 47. Influence of imipramine on neuropeptide Y immunoreactivity in the rat brain.
    Smiałowska M; Legutko B
    Neuroscience; 1991; 41(2-3):767-71. PubMed ID: 1870710
    [TBL] [Abstract][Full Text] [Related]  

  • 48. 2-[125Iodo]LSD, a new ligand for the characterisation and localisation of 5-HT2 receptors.
    Engel G; Müller-Schweinitzer E; Palacios JM
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Apr; 325(4):328-36. PubMed ID: 6728042
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Characterisation of [3H]lysergic acid diethylamide binding to a 5-hydroxytryptamine receptor on human platelet membranes.
    Geaney DP; Schächter M; Elliot JM; Grahame-Smith DG
    Eur J Pharmacol; 1984 Jan; 97(1-2):87-93. PubMed ID: 6698111
    [TBL] [Abstract][Full Text] [Related]  

  • 50. N1-methyl-2-[125I]LSD ([125I]MIL), a preferred ligand for serotonin 5-HT2 receptors.
    Hoffman BJ; Karpa MD; Lever JR; Hartig PR
    Eur J Pharmacol; 1985 Mar; 110(1):147-8. PubMed ID: 4007051
    [No Abstract]   [Full Text] [Related]  

  • 51. Interactions of [3H]LSD with serotonin receptors in human brain.
    Cross AJ
    Eur J Pharmacol; 1982 Aug; 82(1-2):77-80. PubMed ID: 7128680
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Receptor autoradiographical evidence for high densities of 125I-neuropeptide Y binding sites in the nucleus tractus solitarius of the normal male rat.
    Härfstrand A; Fuxe K; Agnati LF; Benfenati F; Goldstein M
    Acta Physiol Scand; 1986 Oct; 128(2):195-200. PubMed ID: 3022555
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Serotonin uptake sites and serotonin receptors are altered in the limbic system of schizophrenics.
    Joyce JN; Shane A; Lexow N; Winokur A; Casanova MF; Kleinman JE
    Neuropsychopharmacology; 1993 Jun; 8(4):315-36. PubMed ID: 8512620
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Quantitative and autoradiographic analyses of alpha-adrenergic and serotonergic receptors on aorta and coronary artery.
    Tsutsui H; Tomoike H; Nakamura M
    Am J Physiol; 1990 Nov; 259(5 Pt 2):H1343-50. PubMed ID: 1978573
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Neuroanatomically selective down-regulation of beta adrenergic receptors by chronic imipramine treatment: relationships to the topography of [3H]imipramine and [3H] desipramine binding sites.
    Duncan GE; Paul IA; Powell KR; Fassberg JB; Stumpf WE; Breese GR
    J Pharmacol Exp Ther; 1989 Jan; 248(1):470-7. PubMed ID: 2536433
    [TBL] [Abstract][Full Text] [Related]  

  • 56. (+)Lysergic acid diethylamide, but not its nonhallucinogenic congeners, is a potent serotonin 5HT1C receptor agonist.
    Burris KD; Breeding M; Sanders-Bush E
    J Pharmacol Exp Ther; 1991 Sep; 258(3):891-6. PubMed ID: 1679849
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of subchronic treatment with neuroleptic, imipramine, and the combination on serotonin receptor binding in rat cerebral cortex.
    Andree TH; Mikuni M; Meltzer HY
    Psychopharmacol Bull; 1984; 20(3):349-53. PubMed ID: 6147873
    [No Abstract]   [Full Text] [Related]  

  • 58. Chronic desipramine treatment reduces regional neuropeptide Y binding to Y2-type receptors in rat brain.
    Widdowson PS; Halaris AE
    Brain Res; 1991 Jan; 539(2):196-202. PubMed ID: 1647239
    [TBL] [Abstract][Full Text] [Related]  

  • 59. 5-Hydroxytryptamine (5-HT)-induced shape change in human platelets determined by computerized data acquisition: correlation with [125I]-iodoLSD binding at 5-HT2 receptors.
    Brazell C; McClue SJ; Preston GC; King B; Stahl SM
    Blood Coagul Fibrinolysis; 1991 Feb; 2(1):17-24. PubMed ID: 1772986
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Site-directed mutagenesis of the serotonin 5-hydroxytrypamine2 receptor: identification of amino acids necessary for ligand binding and receptor activation.
    Wang CD; Gallaher TK; Shih JC
    Mol Pharmacol; 1993 Jun; 43(6):931-40. PubMed ID: 8316224
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.